In Silico Analysis for Determination and Validation of Human CD20 Antigen 3D Structure

Barun B, Bar-Or A (2012) Treatment of multiple sclerosis with anti-CD20 antibodies. Clin Immunol 142(1):31–37 Beers SA, Chan CH, James S, French RR, Attfield KE, Brennan CM, Ahuja A, Shlomchik MJ, Cragg MS, Glennie MJ (2008) Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood 112(10):4170–4177 Berezin C, Glaser F, Rosenberg J, Paz I, Pupko T, Fariselli P, Casadio R, Ben-Tal N (2004) ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics 20(8):1322–1324 Blundell T, Carney D, Gardner S, Hayes F, Howlin B, Hubbard T, Overington J, Singh DA, Sibanda BL, Sutcliffe M (1988) Knowledge-based protein modelling and design. FEBS J 172(3):513–520 Brændstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA (2005) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 78(4):275–280 Carugo O, Djinović-Carugo K (2013) Half a century of Ramachandran plots. Acta Crystallogr Sect D 69(8):1333–1341 Chen J, Liu H, Yang J, Chou K-C (2007) Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids 33(3):423–428 Chen C-C, Hwang J-K, Yang J-M (2009) 2-v2: template-based protein structure prediction server. BMC Bioinform 10(1):366 Cragg MS, Walshe CA, Ivanov AO, Glennie MJ (2004) The biology of CD20 and its potential as a target for mAb therapy. B cell trophic factors and B cell antagonism in autoimmune disease. Karger Publ 8:140–174 Deng X, Liu Q, Hu Y, Deng Y (2013) TOPPER: topology prediction of transmembrane protein based on evidential reasoning. Sci World J 2013:8 Du J, Yang H, Guo Y, Ding J (2009) Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20. Mol Immunol 46(11):2419–2423 EL-Manzalawy Y, Dobbs D, Honavar V (2008) Predicting linear B-cell epitopes using string kernels. J Mol Recogn 21(4):243–255 Ernst JA, Li H, Kim HS, Nakamura GR, Yansura DG, Vandlen RL (2005) Isolation and characterization of the B-cell marker CD20. Biochemistry 44(46):15150–15158 Farag SS, Flinn IW, Modali R, Lehman TA, Young D, Byrd JC (2004) FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia. Blood 103(4):1472–1474 Fiser A (2004) Protein structure modeling in the proteomics era. Expert Rev Proteomics 1(1):97–110 Floudas C, Fung H, McAllister S, Mönnigmann M, Rajgaria R (2006) Advances in protein structure prediction and de novo protein design: a review. Chem Eng Sci 61(3):966–988 Gasteiger E, Hoogland C, Gattiker A, Duvaud Se, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. Springer, New York Geourjon C, Deleage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics 11(6):681–684 Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner CM, Chagorova T, de la Serna J, Dilhuydy M-S, Illmer T (2014) Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med 370(12):1101–1110 Golay J, Semenzato G, Rambaldi A, Foà R, Gaidano G, Gamba E, Pane F, Pinto A, Specchia G, Zaja F (2013) Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. MAbs 5(6):826–837 Haste Andersen P, Nielsen M, Lund O (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15(11):2558–2567 Jaglowski SM, Alinari L, Lapalombella R, Muthusamy N, Byrd JC (2010) The clinical application of monoclonal antibodies in chronic lymphocytic leukemia. Blood 116(19):3705–3714 Jahangiri A, Rasooli I, Owlia P, Fooladi AAI, Salimian J (2017) In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of outer membrane protein A. Microb Pathog 105:201–210 Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845–858 Khalili S, Rahbar MR, Dezfulian MH, Jahangiri A (2015) In silico analyses of Wilms׳ tumor protein to designing a novel multi-epitope DNA vaccine against cancer. J Theor Biol 379:66–78 Khalili S, Mohammadpour H, BAROUGH MS, Kokhaei P (2016) ILP-2 modeling and virtual screening of an FDA-approved library: a possible anticancer therapy. Turkish J Med Sci 46(4):1135–1143 Khalili S, Jahangiri A, Hashemi ZS, Khalesi B, Mardsoltani M, Amani J (2017a) Structural pierce into molecular mechanism underlying Clostridium perfringens Epsilon toxin function. Toxicon 127:90–99 Khalili S, Rasaee M, Bamdad T (2017b) 3D structure of DKK1 indicates its involvement in both canonical and non-canonical Wnt pathways. Mol Biol 51(1):155–166 Khalili S, Zakeri A, Hashemi ZS, Masoumikarimi M, Manesh MRR, Shariatifar N, Sani MJ (2017c) Structural analyses of the interactions between the thyme active ingredients and human serum albumin. Turkish J Biochem 42:459–467 Krogh A, Larsson B, Von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305(3):567–580 Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7(3):115–121 Lin H-N, Sung T-Y, Ho S-Y, Hsu W-L (2010) Improving protein secondary structure prediction based on short subsequences with local structure similarity. BMC Genom 11(4):S4 Liu W, Chen Y (2005) High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins. Eur J Immunol 35(2):505–514 Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL (2012) OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res 40(D1):D370–D376 Lunning MA, Vose JM, Schreeder MT, Fowler N, Nastoupil LJ, Siddiqi T, Blumel S, Pauli EK, Cutter K, Tse W (2014) Ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody (mAb), in combination with TGR-1202, a next generation once daily PI3kδ inhibitor, demonstrates activity in heavily pre-treated and high-risk chronic lymphocytic leukemia (CLL) and B-cell lymphoma. Am Soc Hematology 124(21):801 McGuffin LJ, Bryson K, Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16(4):404–405 McLaughlin P, Grillo-López AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16(8):2825–2833 Mihăşan M (2010) Basic protein structure prediction for the biologist: a review. Arch Biol Sci 62(4):857–871 Mohammadpour H, Khalili S, Hashemi ZS (2015) Kremen is beyond a subsidiary co-receptor of Wnt signaling: an in silico validation. Turk J Biol 39(3):501–510 Mohammadpour H, Pourfathollah AA, Zarif MN, Khalili S (2016) Key role of Dkk3 protein in inhibition of cancer cell proliferation: an in silico identification. J Theor Biol 393:98–104 Pawluczkowycz AW, Beurskens FJ, Beum PV, Lindorfer MA, van de Winkel JG, Parren PW, Taylor RP (2009) Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX. J Immunol 183(1):749–758 Payandeh Z, Rajabibazl M, Mortazavi Y, Rahim-Pour A, Taromchi AH (2017) Ofatumumab monoclonal antibody affinity maturation through in silico modeling. Iran Biomed J 0(0):0–0 Petrey D, Honig B (2005) Protein structure prediction: inroads to biology. Mol Cell 20(6):811–819 Polyak MJ, Tailor SH, Deans JP (1998) Identification of a cytoplasmic region of CD20 required for its redistribution to a detergent-insoluble membrane compartment. J Immunol 161(7):3242–3248 Ponomarenko J, Bui H-H, Li W, Fusseder N, Bourne PE, Sette A, Peters B (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform 9(1):514 Reff ME, Carner K, Chambers K, Chinn P, Leonard J, Raab R, Newman R, Hanna N, Anderson D (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83(2):435–445 Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725–738 Roy A, Yang J, Zhang Y (2012) COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res 40(W1):W471–W477 Rubinstein ND, Mayrose I, Martz E, Pupko T (2009) Epitopia: a web-server for predicting B-cell epitopes. BMC Bioinform 10(1):287 Salles G, Morschhauser F, Lamy T, Milpied N, Thieblemont C, Tilly H, Bieska G, Asikanius E, Carlile D, Birkett J (2012) Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients. Blood 119(22):5126–5132 Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31(13):3381–3385 Sefid F, Rasooli I, Jahangiri A, Bazmara H (2015) Functional exposed amino acids of BauA as potential immunogen against Acinetobacter baumannii. Acta Biotheor 63(2):129–149 Sefid F, Rasooli I, Payandeh Z (2016) Homology modeling of a Camelid antibody fragment against a conserved region of Acinetobacter baumannii biofilm associated protein (Bap). J Theor Biol 397:43–51 Sharman JP, Farber CM, Mahadevan D, Schreeder MT, Brooks HD, Kolibaba KS, Fanning SR, Klein LM, Sportelli P, Miskin HP (2014) Ublituximab (TG-1101), a novel glycoengineered anti-CD20 monoclonal antibody, in combination with ibrutinib is highly active in patients with relapsed and/or refractory CLL and MCL; results of a phase II trial. Am Soc Hematol 4679 Somarowthu S, Ondrechen MJ (2012) POOL server: machine learning application for functional site prediction in proteins. Bioinformatics 28(15):2078–2079 Stroopinsky D, Katz T, Rowe JM, Melamed D, Avivi I (2012) Rituximab-induced direct inhibition of T-cell activation. Cancer Immunol Immunother 61(8):1233–1241 Tedder TF, Streuli M, Schlossman SF, Saito H (1988) Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci USA 85(1):208–212 Tsirigos KD, Peters C, Shu N, Käll L, Elofsson A (2015) The TOPCONS web server for consensus prediction of membrane protein topology and signal peptides. Nucleic acids Res 43(W1):W401–W407 van Meerten T, Hagenbeek A (2010). CD20-targeted therapy: the next generation of antibodies. Seminars in hematology, Elsevier, Amsterdam Viklund H, Elofsson A (2008) OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar. Bioinformatics 24(15):1662–1668 Volkamer A, Kuhn D, Rippmann F, Rarey M (2012) DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28(15):2074–2075 Wierda WG, Kipps TJ, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, Robak T, Furman RR, Hillmen P, Trneny M (2010) Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. J Clin Oncol 28(10):1749–1755 Wu S, Zhang Y (2007) LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res 35(10):3375–3382 Wu S, Zhang Y (2008) MUSTER: improving protein sequence profile–profile alignments by using multiple sources of structure information. Proteins 72(2):547–556 Xu D, Zhang Y (2011) Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 101(10):2525–2534 Yang J, Roy A, Zhang Y (2013) Protein–ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment. Bioinformatics 29(20):2588–2595 Yu CS, Chen YC, Lu CH, Hwang JK (2006) Prediction of protein subcellular localization. Proteins 64(3):643–651 Yu C-S, Cheng C-W, Su W-C, Chang K-C, Huang S-W, Hwang J-K, Lu C-H (2014) CELLO2GO: a web server for protein subCELlular LOcalization prediction with functional gene ontology annotation. PLoS ONE 9(6):e99368 Zhang B (2009). Ofatumumab. MAbs, Taylor & Francis, Routledge